CRISPR Therapeutics AG (1CG.MU)
42.33+0.02%
StockGlow Score
Bearish
BearishBullish
1 year ago-13.3%
The outlook
CRISPR Therapeutics AG currently reads as bearish based on below its 50- & 200-day averages, 11% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
—
52-wk high
66.50
52-wk low
39.20
50-day avg
45.92
200-day avg
46.05
Trailing P/E
—